ReviewJournal of bone and mineral metabolism2026
Inflammaging in periodontal, periapical, and malignancy-associated disease: drivers of alveolar bone loss and repair.
Review in Journal of bone and mineral metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrin Signaling Imbalance in Periodontitis: A Stage-Dependent Link Between Inflammation, Bone Resorption and Regenerative Failure.Biomolecules · 2026Review
- Revisiting inflammaging: a critical appraisal of its role in alveolar bone loss.Journal of bone and mineral metabolism · 2026Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
Abstract
backgroundAging significantly impacts bone metabolism through altered osteoblast/osteoclast dynamics, reduced stem cell regeneration, and chronic inflammaging. This narrative review explores how these age-related changes influence alveolar bone loss and regeneration in the oral cavity.
methodsThe review investigates key mechanisms-including immunosenescence and inflammasome activation-across three specific pathological contexts: (1) periodontitis, (2) periapical bone resorption, and (3) malignancy-associated osteolysis. Preclinical and clinical evidence were integrated to analyze the bone-immune equilibrium.
resultsAging was found to skew the immune environment, exacerbating bone destruction. The review identifies emerging immunomodulatory strategies to rejuvenate bone healing, such as targeting senescent cells (senolytics) and inflammatory cytokines to modulate the immune microenvironment.
conclusionAddressing the unique challenges of the aging population is critical for regenerative dentistry. Future research must bridge current gaps to translate immunomodulatory insights into clinical therapies for improving alveolar bone regeneration in older patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.